Clinical and economic impact of diabetes mellitus on percutaneous and surgical treatment of multivessel coronary disease patients: Insights from the arterial revascularization therapy study (ARTS) trial

Circulation

Volumn 104, Issue 5, 2001, Pages 533-538

  Abizaid, Alexandre ^a   Costa, Marco A ^a,b   Centemero, Marinella ^a   Abizaid, Andrea S ^a   Legrand, Victor M G ^e   Limet, Robert V ^e   Schuler, Gerhard ^f   Mohr, Friedrich W ^f   Lindeboom, Wietze ^c   Sousa, Amanda G M R ^a   Sousa, J Eduardo ^a   Van Hout, Ben ^d   Hugenholtz, Paul G ^d   Unger, Felix ^g   Serruys, Patrick W ^b  

^a INSTITUTO DANTE PAZZANESE DE CARDIOLOGIA   (Brazil)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c CARDIALYSIS   (Netherlands)

^d ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^e UNIVERSITY OF LIÈGE   (Belgium)

^f UNIVERSITY OF LEIPZIG HEART CENTER   (Germany)

^g Salzburger Landeskliniken   (Austria)

Author keywords

Coronary disease; Diabetes mellitus; Revascularization

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; CORONARY ARTERY RECANALIZATION; CORONARY BLOOD VESSEL; DIABETES MELLITUS; ECONOMIC ASPECT; FEMALE; FOLLOW UP; HUMAN; IMPLANTATION; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SURVIVAL RATE;

EID: 0035979350     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/hc3101.093700     Document Type: Article

References (35)

1. Restenosis after arterial injury caused by coronary stenting in patients with diabetes mellitus
2. Influence of diabetes mellitus on early and late outcome after percutaneous transluminal coronary angioplasty
3. Coronary angioplasty in diabetic patients. The National Heart, Lung, and Blood Institute Percutaneous Transluminal Coronary Angioplasty Registry
4. The influence of diabetes mellitus on acute and late clinical outcomes following coronary stent implantation
5. Diabetes mellitus and the clinical and angiographic outcome after coronary stent placement
6. Restenosis rates in diabetic patients: A comparison of coronary stenting and balloon angioplasty in native coronary vessels
7. Influence of diabetes on 5-year mortality morbidity in a randomized trial comparing CABG and PTCA in patients with multivessel disease: The Bypass Angioplasty Revascularization Investigation (BARI)
8. Eight year mortality in the Emory Angioplasty vs. Surgery Trial (EAST)
9. Comparison of coronary bypass surgery with angioplasty in patients with multivessel disease
10. A randomized trial comparing coronary angioplasty with coronary bypass surgery. Emory Angioplasty versus Surgery Trial (EAST)
11. A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease
12. A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease
13. A comparison of coronary-artery stenting with angioplasty for isolated stenosis of the proximal left anterior descending coronary artery
14. Randomised comparison of implantation of heparin-coated stents with balloon angioplasty in selected patients with coronary artery disease (Benestent II)
15. Coronary-artery stenting compared with balloon angioplasty for restenosis after initial balloon angioplasty
16. Use of internal thoracic artery for coronary artery grafting
17. Low recurrence of angina pectoris after coronary artery bypass graft surgery with bilateral internal thoracic and right gastroepiploic arteries
18. Randomized comparison of coronary artery bypass surgery and stenting for the treatment of multivessel disease
19. Secular trends in Q wave and non-Q wave acute myocardial infarction. The Minnesota Heart Survey
20. Cost effectiveness of stent implantation versus PTCA: The BENESTENT experience
21. Estimation of a common effect parameter from sparse follow-up data
22. Minimally invasive coronary artery bypass grafting: An experimental perspective
23. Multicenter review of preoperative risk factors for stroke after coronary artery bypass grafting
24. Long-term angiographic follow-up of coronary balloon angioplasty in patients with diabetes mellitus: A clue to the explanation of the results of the BARI study. Balloon Angioplasty Revascularization Investigation
25. Importance of considering atherosclerosis progression when choosing a coronary revascularization strategy: The diabetes-percutaneous transluminal coronary angioplasty dilemma
26. Luminal narrowing after percutaneous transluminal coronary angioplasty: A study of clinical, procedural, and lesional factors related to long-term angiographic outcome
27. Restenosis after percutaneous transluminal coronary angioplasty (PTCA): A report from the PTCA Registry of the National Heart, Lung, and Blood Institute
28. Restenosis after coronary angioplasty: A multivariate statistical model to relate lesion and procedure variables to restenosis
29. Restenosis, late vessel occlusion and left ventricular function six months after balloon angioplasty in diabetic patients
30. Increased restenosis in diabetes mellitus after coronary interventions is due to exaggerated intimal hyperplasia: A serial intravascular ultrasound study
31. Thromboxane biosynthesis and platelet function in type II diabetes mellitus
32. Optimizing the percutaneous interventional outcomes for patients with diabetes mellitus: Results of the EPISTENT (Evaluation of Platelet IIb/IIIa Inhibitor for Stenting Trial) diabetic substudy
33. A subgroup analysis of the Scripps Coronary Radiation to Inhibit Proliferation Poststenting Trial
34. Lack of neointimal proliferation after implantation of sirolimus-coated stents in human coronary arteries: A QCA and three-dimensional IVUS study
35. Restenosis: The cost to society